| Clinical data | |
|---|---|
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C16H14ClF3N2O |
| Molar mass | 342.75 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
LGD-3303 is a drug which acts as aselective androgen receptor modulator (SARM), with good oral bioavailability. It is a selective agonist for theandrogen receptor, producingfunctional selectivity with effective dissociation ofanabolic andandrogenic effects, acting as a partial agonist for androgenic effects, but a full agonist for anabolic effects.[1] It has been investigated as a possible treatment forosteoporosis, and was shown in animal studies to enhance the effectiveness of abisphosphonate drug.[2]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |